BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martin I, Baldomero H, Bocelli-tyndall C, Passweg J, Saris D, Tyndall A. The Survey on Cellular and Engineered Tissue Therapies in Europe in 2010. Tissue Engineering Part A 2012;18:2268-79. [DOI: 10.1089/ten.tea.2012.0169] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Sonnaert M, Papantoniou I, Bloemen V, Kerckhofs G, Luyten FP, Schrooten J. Human periosteal-derived cell expansion in a perfusion bioreactor system: proliferation, differentiation and extracellular matrix formation. J Tissue Eng Regen Med 2017;11:519-30. [PMID: 25186024 DOI: 10.1002/term.1951] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
2 Christodoulou I, Kolisis FN, Papaevangeliou D, Zoumpourlis V. Comparative Evaluation of Human Mesenchymal Stem Cells of Fetal (Wharton's Jelly) and Adult (Adipose Tissue) Origin during Prolonged In Vitro Expansion: Considerations for Cytotherapy. Stem Cells Int 2013;2013:246134. [PMID: 23533440 DOI: 10.1155/2013/246134] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 6.4] [Reference Citation Analysis]
3 Martin I, Baldomero H, Bocelli-Tyndall C, Emmert MY, Hoerstrup SP, Ireland H, Passweg J, Tyndall A. The survey on cellular and engineered tissue therapies in Europe in 2011. Tissue Eng Part A 2014;20:842-53. [PMID: 24090467 DOI: 10.1089/ten.TEA.2013.0372] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
4 Huang Z, Odeleye AOO, Ye H, Cui Z, Yang A. Fluid dynamic characterization of a fluidized-bed perfusion bioreactor with CFD-DEM simulation: CFD-DEM simulation of a fluidized-bed perfusion bioreactor. J Chem Technol Biotechnol 2018;93:2316-30. [DOI: 10.1002/jctb.5576] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 de Windt T, Niemansburg S, Vonk L, van Delden J, Roes K, Dhert W, Saris D, Bredenoord A. Ethics in musculoskeletal regenerative medicine; guidance in choosing the appropriate comparator in clinical trials. Osteoarthritis and Cartilage 2019;27:34-40. [DOI: 10.1016/j.joca.2018.08.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Sonnaert M, Papantoniou I, Luyten FP, Schrooten JI. Quantitative Validation of the Presto Blue Metabolic Assay for Online Monitoring of Cell Proliferation in a 3D Perfusion Bioreactor System. Tissue Eng Part C Methods 2015;21:519-29. [PMID: 25336207 DOI: 10.1089/ten.TEC.2014.0255] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
7 Gay MHP, Baldomero H, Farge-Bancel D, Robey PG, Rodeo S, Passweg J, Müller-Gerbl M, Martin I. The Survey on Cellular and Tissue-Engineered Therapies in Europe in 2016 and 2017. Tissue Eng Part A 2021;27:336-50. [PMID: 32680446 DOI: 10.1089/ten.TEA.2020.0092] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Forrester JV, Steptoe RJ, Klaska IP, Martin-Granados C, Dua HS, Degli-Esposti MA, Wikstrom ME. Cell-based therapies for ocular inflammation. Prog Retin Eye Res. 2013;35:82-101. [PMID: 23542232 DOI: 10.1016/j.preteyeres.2013.02.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
9 Vonk LA, de Windt TS, Slaper-Cortenbach IC, Saris DB. Autologous, allogeneic, induced pluripotent stem cell or a combination stem cell therapy? Where are we headed in cartilage repair and why: a concise review. Stem Cell Res Ther 2015;6:94. [PMID: 25976213 DOI: 10.1186/s13287-015-0086-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
10 Ulrich D, Edwards SL, Su K, Tan KS, White JF, Ramshaw JA, Lo C, Rosamilia A, Werkmeister JA, Gargett CE. Human endometrial mesenchymal stem cells modulate the tissue response and mechanical behavior of polyamide mesh implants for pelvic organ prolapse repair. Tissue Eng Part A. 2014;20:785-798. [PMID: 24083684 DOI: 10.1089/ten.tea.2013.0170] [Cited by in Crossref: 21] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
11 Bakhtina A, Tohfafarosh M, Lichtler A, Arinzeh TL. Characterization and differentiation potential of rabbit mesenchymal stem cells for translational regenerative medicine. In Vitro Cell Dev Biol -Animal 2014;50:251-60. [DOI: 10.1007/s11626-013-9702-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
12 Shin YS, Yoon JR, Kim HS, Lee SH. Intra-Articular Injection of Bone Marrow-Derived Mesenchymal Stem Cells Leading to Better Clinical Outcomes without Difference in MRI Outcomes from Baseline in Patients with Knee Osteoarthritis. Knee Surg Relat Res. 2018;30:206-214. [PMID: 29983008 DOI: 10.5792/ksrr.17.201] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
13 Bara JJ, Herrmann M, Evans CH, Miclau T, Ratcliffe A, Richards RG. Improving translation success of cell-based therapies in orthopaedics. J Orthop Res 2016;34:17-21. [PMID: 26403666 DOI: 10.1002/jor.23055] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
14 Tyndall A. Mesenchymal stem cell treatments in rheumatology: a glass half full? Nat Rev Rheumatol 2014;10:117-24. [PMID: 24217581 DOI: 10.1038/nrrheum.2013.166] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 5.7] [Reference Citation Analysis]
15 Koliakos G. Stem Cells and Aging. Rejuvenation Research 2017;20:4-8. [DOI: 10.1089/rej.2016.1809] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ireland H, Gay MH, Baldomero H, De Angelis B, Baharvand H, Lowdell MW, Passweg J, Martin I. The survey on cellular and tissue-engineered therapies in Europe and neighboring Eurasian countries in 2014 and 2015. Cytotherapy 2018;20:1-20. [DOI: 10.1016/j.jcyt.2017.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
17 Gratwohl A, Baldomero H, Passweg J. Hematopoietic stem cell transplantation activity in Europe: . Current Opinion in Hematology 2013;20:485-93. [DOI: 10.1097/moh.0b013e328364f573] [Cited by in Crossref: 42] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
18 Bt Hj Idrus R, Abas A, Ab Rahim F, Saim AB. Clinical Translation of Cell Therapy, Tissue Engineering, and Regenerative Medicine Product in Malaysia and Its Regulatory Policy. Tissue Eng Part A 2015;21:2812-6. [PMID: 26192075 DOI: 10.1089/ten.TEA.2014.0521] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
19 Martin I, Ireland H, Baldomero H, Passweg J. The survey on cellular and engineered tissue therapies in Europe in 2012. Tissue Eng Part A 2015;21:1-13. [PMID: 25425342 DOI: 10.1089/ten.TEA.2014.0515] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
20 Bocelli-tyndall C, Trella E, Frachet A, Zajac P, Pfaff D, Geurts J, Heiler S, Barbero A, Mumme M, Resink TJ, Schaeren S, Spagnoli GC, Tyndall A. FGF2 induces RANKL gene expression as well as IL1β regulated MHC class II in human bone marrow-derived mesenchymal progenitor stromal cells. Ann Rheum Dis 2014;74:260-6. [DOI: 10.1136/annrheumdis-2013-204235] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
21 Wong KL, Lee KB, Tai BC, Law P, Lee EH, Hui JH. Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years' follow-up. Arthroscopy. 2013;29:2020-2028. [PMID: 24286801 DOI: 10.1016/j.arthro.2013.09.074] [Cited by in Crossref: 234] [Cited by in F6Publishing: 207] [Article Influence: 29.3] [Reference Citation Analysis]
22 Niemansburg SL, Teraa M, Hesam H, van Delden JJ, Verhaar MC, Bredenoord AL. Stem cell trials for cardiovascular medicine: ethical rationale. Tissue Eng Part A 2014;20:2567-74. [PMID: 24164351 DOI: 10.1089/ten.TEA.2013.0332] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
23 Niemansburg SL, Tempels TH, Dhert WJ, van Delden JJ, Bredenoord AL. Societal impacts of regenerative medicine: reflections on the views of orthopedic professionals. Regen Med 2015;10:17-24. [PMID: 25562349 DOI: 10.2217/rme.14.69] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
24 Martin I, Ireland H, Baldomero H, Dominici M, Saris DB, Passweg J. The Survey on Cellular and Engineered Tissue Therapies in Europe in 2013. Tissue Engineering Part A 2016;22:5-16. [DOI: 10.1089/ten.tea.2015.0416] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
25 Sharma B, Fermanian S, Gibson M, Unterman S, Herzka DA, Cascio B, Coburn J, Hui AY, Marcus N, Gold GE. Human cartilage repair with a photoreactive adhesive-hydrogel composite. Sci Transl Med. 2013;5:167ra6. [PMID: 23303605 DOI: 10.1126/scitranslmed.3004838] [Cited by in Crossref: 189] [Cited by in F6Publishing: 174] [Article Influence: 21.0] [Reference Citation Analysis]